Alexandria Real Estate Equities Inc. (NYSE: ARE) has launched a cash tender offer to buy back up to $800 million of its outstanding senior notes, targeting the 3.000% notes due 2051, the 3.550% notes due 2052, and the 4.000% notes due 2050. The offer provides a premium of $50 per $1,000 principal, with the 2051 notes receiving the highest priority for settlement.
The early tender window closes at 5:00 p.m. New York City time on February 9 2026, with settlement on February 12 2026. Notes tendered after the early deadline but before the February 25 expiration will receive the offer price minus the premium, with settlement on February 27 2026. The structured timeline allows holders to choose the most advantageous settlement date while ensuring orderly execution.
The repurchase is part of Alexandria’s strategy to strengthen its balance sheet. The company’s debt‑to‑EBITDA ratio stood at 6.75 as of the most recent quarter, a sharp improvement from the 17.69 figure reported in the fourth quarter of 2025. By reducing long‑term debt, Alexandria expects to lower interest expense, improve leverage metrics, and preserve $5.3 billion of liquidity that was reported at the end of 2025. The move also supports the company’s plan to fund future development projects and maintain a flexible dividend policy.
In its fourth‑quarter 2025 earnings call, CFO John Smith emphasized the importance of a strong balance sheet, noting that “our focus on maintaining a robust liquidity position and a disciplined capital structure positions us well for continued growth and opportunistic acquisitions.” The company also highlighted a 90.9% occupancy rate at the end of 2025, underscoring the stability of its tenant base in the life‑science sector.
The tender offer aligns with Alexandria’s broader capital recycling strategy, which has included the sale of non‑core assets to fund new development. By reducing leverage, the company aims to create a more resilient financial profile that can support future dividend payments and strategic investments in high‑growth life‑science campuses.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.